December 21, 2011 - GenMark Diagnostics announced today that it has submitted to the U.S. Food and Drug Administration (FDA), for 510(k) clearance, a Respiratory Viral Panel for use on its eSensor® XT-8 system.
November 10, 2011 - GenMark Diagnostics, Inc. (Nasdaq:GNMK) today reported financial results for the third quarter ended September 30, 2011.
eSensor® XT-8 System
The eSensor® XT-8 system is the second generation in GenMark Dx’s eSensor platform, utilizing unique electrochemical detection technology to detect nucleic acids on a microarray. The XT-8 is a complete benchtop system for making complex testing simple.
